Read the latest epilepsy news from Epilepsy Society.
GP practice could close after failure to warn women of risks around sodium valproate
15 August 2018
A GP practice in London could be closed down after inspectors found that staff had failed to warn women of the risks around the epilepsy medication sodium valproate...
Epilepsy Society-based neuropsychologist Sallie Baxendale wins international award
14 August 2018
Neuropsychologist Sallie Baxendale, based at Epilepsy Society, has scooped a prestigious international award for the significant difference she has made to the...
Epilepsy Society responds to reports of medicine stockpiling in advance of Brexit
1 August 2018
Epilepsy Society responds to media reports around stockpiling drugs in case there are supply problems following a possible hard Brexit.
Epilepsy Society welcomes Government decision to relax licensing of medicinal cannabis
27 July 2018
A government decision to relax the licensing laws around cannabis-derived medicinal products has been welcome by Epilepsy Society.
Protein found in worms helps to stop seizure activity
16 July 2018
Exciting new research that involves using a protein in worms to suppress seizures, could spell hope in the future for thousands of people with epilepsy.
Epilepsy Society's CEO writes to Flynn Pharma and Pfizer on NHS's 70th Birthday
5 July 2018
Epilepsy Society's CEO, Clare Pelham, wrote to the pharmaceutical companies Flynn Pharma and Pfizer to ask them to give a birthday present to the NHS.
Epilepsy Society welcomes government response to Billy Caldwell case
16 June 2018
Epilepsy Society welcomes Home Office decision to return the cannabis oil that it confiscated from mother of boy with severe epilepsy.
Tribunal overrules findings in case involving epilepsy drug
8 June 2018
A decision by the Competition and Markets Authority to fine Pfizer and Flynn Pharma a total of £90m for overcharging for an epilepsy drug, has been remitted back to...
Clare Pelham comments on new sodium valproate regulations
30 April 2018
Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.